This article is more than 5 years old. Information may no longer be current.

Synergetics reports $1.9 million fourth-quarter net income

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Synergetics USA reported a net income of $1.94 million for the fourth quarter, which ended July 31, compared to $2.04 million in the fourth quarter last year, according to a press release.

Net income for the fiscal year was $5.59 million, compared to $5.63 million for the 2011 fiscal year, the release said.

“Our base ophthalmic business decelerated in the fourth quarter,” David M. Hable, Synergetics president and CEO, said in the release. “However, we recorded strong performance in the emerging markets of Brazil, Russia and India, as well as continued account penetration in the U.S. with VersaPACK, trends that bode well for Synergetics’ long-term growth prospects.”

The company reported $60 million in total sales for the year, up 7.8% over 2011. Total ophthalmic sales increased 2%. The company expects an increase in ophthalmic sales in the second half of the 2013 fiscal year following the recent regulatory approval of the VersaVIT portable vitrectomy machine, the release said.